Elevated Concentrations of SERPINE2Protease Nexin-1 and Secretory Leukocyte Protease Inhibitor in the Serum of Patients with Papillary Thyroid Cancer

Abstract EN

Introduction.

SERPINE2 and secretory leukocyte protease inhibitor (SLPI) are proteins with anticoagulant properties which could promote solid tumor growth.

However, their role in the pathogenesis of thyroid cancer has not been determined.

Materials and Methods.

The aim of this study was to assess serum SERPINE2 and SLPI concentrations in a group of 36 patients with papillary thyroid cancer (PTC) and a group of 19 subjects with multinodular nontoxic goiter (MNG).

The control group (CG) consisted of 20 healthy volunteers.

Blood samples were collected one day before surgery.

Serum SERPINE2 and SLPI concentrations were measured using specific ELISA methods.

Results.

Significantly higher concentrations of SERPINE2 and SLPI were found in patients with PTC as compared with MNG and controls.

Positive correlation was found between SERPINE2 and SLPI concentrations in PTC patients.

The levels of SERPINE2 and SLPI did not differ significantly between MNG and healthy controls.

Conclusions.

Our results indicate that SERPINE2 and SLPI play a significant role in the development of papillary thyroid cancer and imply that the evaluation of serum concentrations of both anticoagulant molecules may be considered as additional marker for the differentiation of malignancies during the preoperative diagnosis of patients with thyroid gland tumors.